scholarly article | Q13442814 |
P356 | DOI | 10.1016/0959-8049(93)90572-W |
P698 | PubMed publication ID | 1332737 |
P2093 | author name string | D. Stewart | |
D. Osoba | |||
D. Warr | |||
J. Pater | |||
J. Latreille | |||
F. Laberge | |||
L. Kaizer | |||
A. Wilan | |||
G. O'Connell | |||
P. Venner | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Canada | Q16 |
metoclopramide | Q421095 | ||
dexamethasone | Q422252 | ||
granisetron | Q596708 | ||
phase III clinical trial | Q42824827 | ||
P304 | page(s) | 33-36 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | European Journal of Cancer | Q332260 |
P1476 | title | A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial | |
P478 | volume | 29A |
Q55005460 | A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin. |
Q37039597 | Antiemetics: an update and the MASCC guidelines applied in clinical practice |
Q70785527 | Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy |
Q33571897 | Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting |
Q40397083 | Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy |
Q40387103 | Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities |
Q40655344 | Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists |
Q72522017 | [Antiemetic treatment and chemotherapy: general review] |
Q83944098 | [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research] |
Search more.